CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

Conditions:   Advanced Biliary Tract Carcinoma;   Advanced Colorectal Carcinoma;   Advanced Gastroesophageal Junction Adenocarcinoma;   Advanced Lung Adenocarcinoma;   Advanced Malignant Solid Neoplasm;   Advanced Ovarian Carcinoma;   Advanced Pancreatic Carcinoma;   Advanced Urotheli al Carcinoma;   Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8;   Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8;   Metastatic Biliary Tract Carcinoma;   Metastatic Colorectal Carcinoma;   Metastatic Gastroesophageal Junction Adenocarcinoma;   Met astatic Lung Adenocarcinoma;   Metastatic Ovarian Carcinoma;   Metastatic Pancreatic Carcinoma;   Metastatic Urothelial Carcinoma;   Refractory Biliary Tract Carcinoma;   Refractory Colorectal Carcinoma;   Refractory Gastroesophageal Junction Adenocarcinoma;   Refractory Lung A denocarcinoma;   Refractory Ovarian Carcinoma;   Refractory Pancreatic Carcinoma;   Refractory Urothelial Carcinoma;   Stage II Pancreatic Cancer AJCC v8;   Stage III Colorectal Cancer AJCC v8;   Stage III Lung Cancer AJCC v8;   Stage III Ovarian Cancer AJCC v8;   S tage III Pancreatic Cancer AJCC v8;   Stage IV Colorectal Cancer AJCC v8;   Stage IV Lung Cancer AJCC v8;   Stage IV Ovarian Cancer AJCC v8;   Stage IV Pancreatic Cancer AJCC v8 Interventions:   Procedure: Biospecimen Collection;   Procedure: Computed...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials